Depo-Provera (medroxyprogesterone acetate) is an injectable form of birth control and should be used only for long term (2 years or more) birth control. Depo-Provera (medroxyprogesterone acetate) should be used as a long-term birth control method (e.g. longer than 2 years) and only if other birth controls methods are inadequate. Depo-Provera (medroxy-progesterone acetate) can also be used to relieve painful menstruation; abnormal bleeding due to hormonal imbalance and is used to reduce unusual tissue growth in the mucous membrane that lines the womb for menopausal women receiving estrogen. A use being investigated for Depo-Provera (medroxyprogesterone acetate) is in the treatment of polycystic ovary syndrome, slow puberty and for treatment of advanced breast cancer.

A licensed online Canada pharmacy requires a prescription from a doctor before it will ship your order for this product. Any Canada drugs store that will let you buy Depo-Provera (medroxyprogesterone acetate) online without US or Canadian prescriptions should be avoided. If you buy cheap Depo-Provera (medroxyprogesterone acetate) online from such internet pharmacies, you cannot be certain that your order is supplied by a licensed and reputable Canadian online pharmacy and you will have no assurance of quality.

The recommended dose for Depo-Provera (medroxyprogesterone acetate) being administered for birth control is 150 mg every 3 months (13 weeks) administered by deep, Inter muscular injection in the gluteus or deltoid muscle. To ensure the patient is not pregnant at the time of the first injection, the first injection must be given only during the first 5 days of a normal menstrual period; only within the first 5-days postpartum if not breast-feeding; and if exclusively breast-feeding, only at the sixth postpartum week. If the time interval between injections is greater than 13 weeks, the physician should determine that the patient is not pregnant before administering the drug. The efficacy of Depo-Provera depends on adherence to the dosage schedule of administration.

In the largest clinical trial with Depo-Provera over 3,900 women, who were treated for up to 7 years, reported the following adverse reactions, which may or may not be related to the use Depo-Provera (medroxyprogesterone acetate) of the following adverse reactions that were reported by more than 5% of subjects: Menstrual irregularities either bleeding or amenorrhea, or both were Abdominal pain or discomfort, Weight changes, dizziness headache, weakness or fatigue and nervousness.

Use of Depo-Provera (medroxyprogesterone acetate) reduces serum estrogen levels and is associated with significant loss of bone mineral density (BMD) as bone metabolism accommodates to a lower estrogen level. This loss of BMD is of particular concern during adolescence and early adulthood, a critical period of bone accretion. It is unknown if use of Depo-Provera (medroxyprogesterone acetate) by younger women will reduce peak bone mass and increase the risk for osteoporotic fracture in later life. In both adults and adolescents, the decrease in BMD appears to be at least partially reversible after Depo-Provera medroxyprogesterone acetate) is discontinued and ovarian estrogen production increases. A study to assess the reversibility of loss of BMD in adolescents is ongoing.

It is good medical practice for all women to have annual history and physical examinations, including women using Depo-Provera (medroxyprogesterone acetate) The physical examination, however, may be deferred until after initiation of Depo-Provera (medroxyprogesterone acetate) if requested by the woman and judged appropriate by the clinician. The physical examination should include special reference to blood pressure, breasts, abdomen and pelvic organs, including cervical cytology and relevant laboratory tests. In case of undiagnosed, persistent or recurrent abnormal vaginal bleeding, appropriate measures should be conducted to rule out malignancy. Women with a strong family history of breast cancer or who have breast nodules should be monitored with particular care.